Merck KGaA’s venture capital arm has closed its latest fund, bringing the European conglomerate fresh cash to invest in up-and-coming biotechs. M Ventures raised €600 million, or roughly $677 million,…
The world of biotech isn’t short on big personalities, but it’s not exactly common to see young professionals earning the broad respect of seasoned academics. Yet, Tom Cahill and his team at Newpath…
Once again, congratulations to all 20 extraordinary leaders profiled yesterday at Endpoints’ second annual Women in Biopharma event. We’ll have a transcript and recap for premium subscribers available…
When prominent biotech founder David Sabatini was ousted by the Whitehead Institute and the Howard Hughes Medical Institute this summer over sexual harassment allegations, he fought back with a…
Hongbo Lu was a board member at CrownBio, a preclinical oncology CRO, when a local company — so local it didn’t even have an English name — licensed a c-Met inhibitor from them. Then they didn’t think…
Nomic is trying to develop the world’s highest throughput proteomic platform. It will now do so with another $17 million in tow. The Montreal-based company announced the closing of its Series A…
The first substantial evidence for how mRNA vaccines will hold up against the new Omicron variant was released Tuesday night from scientists in South Africa. The study, conducted by mixing sera from…
The US FDA’s Cardiovascular and Renal Drugs Advisory Committee on Wednesday voted 13-0 that the agency should not approve Reata Pharmaceuticals’ bardoxolone methyl capsules as a treatment to slow the…
Myelodysplastic syndrome is not only hard to say, it’s also hard to explain. So Novartis hired Noma Bar, an artist and illustrator well-known for his simple and striking imagery to create a video that…
Sotio has been on a roll lately. The quiet Czech biotech based in Prague got a massive $315 million raise last week, and now the biotech announced today that it’s joined in on a collaboration with…
